Please use this identifier to cite or link to this item:
|Title:||Patenting Life the American, European and Indian Way|
|Keywords:||Bio-patents (life patents)|
product of nature
|Abstract:||<smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="place"><smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region"> The patent regime heralds an expansion of its protective umbrella to the emerging sphere of biotechnology, full repercussions of it are only just coming to fore. With revolutionary and rapid growth of industry, new legal and ethical questions have burgeoned which require a meticulous and concerned deliberation. This article discusses evolution of patenting life in the United States, Europe, and India. Additionally, implications of each country’s impact on international patent regime in the light of TRIPS Agreement are also studied. The article also explores feasibility of offering similar statutory protection to living organisms manufactured with significant human intervention in India, which thus far has only witnessed a minimal onslaught of patent applications for ‘utility patents’.</smarttagtype></smarttagtype>|
|ISSN:||0975-1076 (Online); 0971-7544 (Print)|
|Appears in Collections:||JIPR Vol.15(1) [January 2010]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.